TNFa has been proposed to underlie synaptic scaling, but the mechanism and functional significance of this remain unclear. In this issue of Neuron, Cingolani et al. demonstrate that TNFa can mediate scaling through the regulation of b3 integrins. Kaneko et al. show that TNFa-dependent synaptic scaling plays an important role in visual cortical plasticity.
Research over the last few years has shown that immune signaling molecules can have important neuromodulatory roles in the central nervous system, regulating processes such as voltage-gated ion channel function, synaptic transmission, and plasticity (Viviani et al., 2007) . Furthermore, it is believed that disregulation of these molecules is associated with several neurodevelopmental and neurological disorders, ranging from autism to schizophrenia (Hornig and Lipkin, 2001) . One immune molecule that has received a lot of recent interest is the proinflammatory cytokine TNFa, because of its known effects on synaptic transmission. TNFa is expressed in the brain and is known to regulate surface expression of AMPA-type glutamate receptors (AMPARs), one of the principal ion channels mediating excitatory transmission in the CNS. Experimentally increasing levels of TNFa rapidly increases the number of AMPARs expressed in the neuronal membrane, resulting in larger spontaneous miniature excitatory postsynaptic currents (mEPSC), while experimentally decreasing TNFa results in AMPAR internalization and smaller mEPSCs (Beattie et al., 2002) . TNFa levels in the brain are also known to be regulated by neural activity. In the hippocampus, for example, TNFa is constitutively released by glial cells, and its release is believed to be suppressed by excess glutamate spilling over from synaptic sites (Stellwagen and Malenka, 2006) . Thus, when overall levels of synaptic activity in the hippocampal network are low, glia will sense a decrease in glutamate release and increase their TNFa production, resulting in a compensatory increase in AMPAR-mediated synaptic events.
This type of regulation is very reminiscent of what is observed during synaptic scaling. Synaptic scaling is a type of bidirectional, homeostatic synaptic plasticity in which the strengths of all the synapses in a neuron are adjusted in response to global changes in neural activity, stabilizing the firing rate of the neuron (Turrigiano and Nelson, 2004) . One experimental manipulation used to study synaptic scaling is to culture neurons under conditions that would either decrease or increase neuronal activity for 1-2 days and then test the effect of this manipulation on AMPAR-mediated synaptic events. For example, adding the voltage-gated Na + channel blocker TTX to the culture media, to chronically reduce neural activity, results in an increase in mEPSC amplitude after 24-48 hr. Interestingly, this type of scaling up of synaptic strength is dependent on TNFa released from glial cells in the culture dish (Stellwagen and Malenka, 2006) . The decreased amount of activity caused by TTX presumably leads to decreased ambient levels of glutamate, causing the glia to release more TNFa and thus causing more AMPAR to be inserted at synaptic sites. Based on this model of synaptic scaling, one would predict that the converse manipulation, in which elevated network activity would cause glia to decrease TNFa production, would result in a decrease in mEPSC amplitude. However, scaling down of synaptic responses does not appear to require TNFa signaling, suggesting that a yet unidentified factor may be involved in this half of the process.
Despite the attractiveness of this model for TNFa function in the CNS, the mechanisms by which TNFa alters surface expression of AMPAR have remained a mystery. Also lacking is a clear demonstration of the functional significance of TNFa-mediated synaptic scaling. In this issue of Neuron, two exciting new studies begin to fill these gaps. The first shows that TNFa causes upregulation of a specific subtype of cell adhesion molecule, b3 integrin, which in turn causes AMPAR insertion into the membrane (Cingolani et al., 2008) . The second study shows that TNFa-mediated scaling is required for normal visual cortical plasticity during development (Kaneko et al., 2008) .
Cingolani et al. set out to study the role of b3 integrins, a type of cell adhesion molecule, in the regulation of synaptic transmission. b3 integrins are heterodimeric transmembrane proteins, which interact with extracellular membrane proteins and other signaling proteins in adjacent cells, and are also enriched in synapses (Chavis and Westbrook, 2001 ). Using cultured hippocampal neurons, the authors found that pharmacologically disrupting the interaction between b3 integrin and its ligands-through the use of echistatin, a peptide derived from viper venom, or a synthetic version of the peptide-results in a rapid and reversible decrease in mEPSC amplitude. This decrease, which occurs within a few minutes, does not depend on the known interactions between integrins and the actin cytoskeleton, nor is it associated with changes in dendritic spine morphology. It does, however, require postsynaptic Ca 2+ entry through NMDA-type glutamate receptors. Interestingly, the effect of echistatin is mediated by selective endocytosis of the GluR2 AMPAR subunit and requires activation of Rap1, a small GTPase associated with integrin signaling. Overexpression of b3 integrin in postsynaptic neurons is also sufficient to increase mEPSC amplitude, and overexpression of a dominant-negative variant decreases mEPSC size. This is consistent with a model in which b3 integrins dynamically regulate synaptic strength by either stabilizing existing GluR2-containing AMPAR or, if their interaction with their ligands is disrupted, by promoting selective endocytosis of these receptors.
Could this be a mechanism for synaptic scaling? The authors tested this by growing neuronal cultures in either TTX (to decrease activity) or in the presence of the GABAA blocker bicuculline (to increase activity). Remarkably, within a few hours of TTX treatment, surface expression levels of b3 integrin increased, as did surface expression of GluR2. In the converse experiment, bicuculline treatment resulted in a smaller but significant reduction in the surface expression of b3 integrin and a somewhat larger decrease in surface levels of GluR2. Knockout mice lacking the b3 integrin gene did not show TTX-induced scaling up of mEPSCs, suggesting that b3 integrins are required for scaling. Finally, application of TNFa resulted in a significant increase in membrane expression of b3 integrins, forging a link between TNFamediated synaptic scaling and integrin signaling. This study extends the previous model by suggesting that the effect of TNFa on AMPAR insertion works by regulating surface expression of b3 integrins. However, the effect of TNFa cannot account for the downregulation of integrin levels associated with conditions of increased activity or with the echistatin-mediated decrease in synaptic transmission, suggesting that the regulation of b3 integrins is likely to be complex.
In the study by Kaneko et (Frenkel and Bear, 2004; Wiesel, 1982) . Using intrinsic optical imaging of the visual cortex-as well as single-unit recordings-to quantify visual input, the authors compared the relative amount of visual input that the cortex receives from each eye, in control and MD animals. In wildtype mice (Tnf +/+ ), the relative amount of input from the open versus deprived eye shifts over the course of a few days of MD. Tnf À/À mice, still showed this shift to some degree, but it was reduced compared to controls. MD is known to induce two temporally distinct phases of plasticity. In the first, inputs from the closed eye weaken, and in the second, inputs from the open eye strengthen (Frenkel and Bear, 2004 These results are consistent with previous findings in which visual deprivation resulted in increased mEPSC amplitudes in visual cortex (Desai et al., 2002; Goel and Lee, 2007) . The fact that the closed eye inputs strengthen in the second phase also supports this view. One inconsistency with this model is that, if the second phase of plasticity is due to a global scaling of synaptic inputs, which should affect all synapses equally, then it is hard to explain why, in control animals, the inputs from the open eye increase significantly more than those of the closed eye, particularly because closed eye inputs don't seem to depress significantly more after day 3 in Tnf À/À mice. One possibility is that the strengthening also requires competitive, Hebbian plasticity, which is facilitated by synaptic scaling. Nevertheless, these experiments provide compelling evidence that TNFa-mediated synaptic scaling plays an important role in visual cortical plasticity during development.
TNFa is not the only molecule implicated in synaptic scaling. Other soluble factors, such as BDNF, or intracellular signaling molecules, such as Arc or CaMKIV, have also been implicated in scaling (Turrigiano, 2007) . This suggests that multiple mechanisms may be at play. A recent study by Ibata et al. (2008) showed that focal application of TTX to a single neuron In the first mode, rapid changes in spike rate trigger intracellular signaling pathways that ultimately regulate surface expression of AMPARs. In the second, long-term changes in network activity cause the release of diffusible factors, such as TNFa, which lead to scaling. b3 integrin-mediated regulation of AMPARs could be a point of convergence of these two pathways.
in a culture dish resulted in scaling up of synaptic inputs received by that cell within 1-2 hr. It is unlikely that blocking the spiking of a single cell would have a significant impact on the levels of glutamate in the dish, causing increased TNFa release. Furthermore, this scaling required a decrease in intracellular Ca 2+ levels. How do we reconcile these observations with the TNFa model? As with other types of synaptic plasticity, it is probable that there will turn out to be different types of homeostatic plasticity, functioning at different timescales and induced under different conditions (Figure 1 ). For example, one type of synaptic scaling may result from relatively rapid changes in the spike output of an individual neuron and would serve as a real-time adjustment of the firing rate of individual cells. This type of scaling would rely on cell-autonomous, intracellular mechanisms, such as Arc or CamKIV. Another type of scaling mechanism could be used to detect global changes in the activity of a network of neurons. These global changes would occur over a slower timescale and involve diffusible factors, such as TNFa or BDNF, that would affect multiple cells in the network. It would be advantageous to a neuron to be able to have separate mechanisms that allow it to adjust its own firing rate independently of other neurons, as well as sense the overall state of network excitability. It is interesting to note that the levels of membrane-associated b3 integrins increase within a few hours of TTX exposure but are also sensitive to TNFa, which normally doesn't increase until after 1-2 days of TTX exposure. This means that multiple mechanisms may be able to regulate b3 integrin function, suggesting that integrin signaling could be a point of convergence of these different types of synaptic scaling. Future experiments addressing the functional and mechanistic roles of these other molecules, as well a more detailed understanding of b3 integrin regulation, are likely to allow our knowledge in this field to ''scale'' new heights.
Insulin is well known for its critical role in controlling metabolism through the uptake of glucose into cells in most parts of the body-with the notable exception of the brain. Insulin is a peptide hormone, normally secreted by the pancreas in response to increasing levels of blood glucose. Until about 15 years ago, the brain was considered ''insulin-insensitive'' based on early observations that glucose uptake into CNS neurons is not insulin dependent. However, recent reports suggest that insulin can promote the utilization of glucose in some brain areas (Park, 2001 ). These observations, combined with the discovery of insulin receptor (IR) expression in the brain (Havrankova et al., 1978) , lead to the hypothesis that the brain may be an insulin target. Recently, numerous reports have shown that brain IRs regulate diverse aspects of neuronal development, survival, function, plasticity, and perhaps even cognitive function and aging. Despite these exciting reports, the role of IRs in regulating the establishment and function of neuronal circuits in vivo has remained unknown-until the report by Chiu et al. (2008) in this issue of Neuron.
Excitement about the role of insulin in the CNS stems from human studies
